Microscopic images of the various types of fat tissues developed in mice after transplantation. Top panels show the fat tissue’s general morphology, and the bottom panels are the tissue sections stained with hUCP1 (red color), which is unique for brown fat cells. These images show that while the HUMBLE fat cells are morphologically similar to the white fat cells, they express the brown fat specific hUCP1 protein. (Joslin Diabetes Center)
Studies in mice offer a proof of concept that ‘HUMBLE’ cells, created from human white fat, can treat metabolic diseases.
Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year than the Covid-19 coronavirus. Scientists at Joslin Diabetes Center have delivered a proof of concept for a novel cell-based therapy against this dangerous condition.
The potential therapy for obesity would transplant HUMBLE (human brown-like) fat cells, human white fat cells that have been genetically modified to become similar to heat-generating brown fat cells, says Yu-Hua Tseng, PhD, a Senior Investigator in Joslin’s Section on Integrative Physiology and Metabolism.
Brown fat cells burn energy instead of storing energy as white fat cells do, says Tseng, senior author on a paper about the work in Science Translational Medicine . In the process, brown fat can lower excessive levels of glucose and lipids in the blood that are linked to metabolic diseases such as diabetes.
However, people who are overweight or obese tend to have less of this beneficial brown fat—a barrier that HUMBLE cells are designed to overcome, Tseng says.
She and her colleagues created the cells from human white fat cells in a progenitor stage (not yet fully developed into their final fat form). The investigators used a variant of the CRISPR-Cas9 genome editing system to boost expression of a gene called UCP1, which triggers white fat cell progenitors to develop into brown fat-like cells.
Transplanted into mice lacking an immune system, the HUMBLE progenitor cells developed into cells that functioned very much like the mice’s own brown fat cells, says Tseng, who is also a professor of medicine at Harvard Medical School.
Her team compared transplants of these cells versus the original white fat cells in mice who were put on a high fat diet. Mice given the HUMBLE transplants displayed much greater sensitivity to insulin and ability to clear glucose from the blood (two key factors that are impaired in type 2 diabetes).
Additionally, the mice receiving HUMBLE transplants put on less weight than mice with transplanted white fat cells, remaining in the same range as animals who received brown fat cells.
Perhaps surprisingly, the Joslin scientists demonstrated that these benefits were mostly due to signals from the transplanted cells to endogenous (existing) brown fat cells in the mice. “Cells in different tissues communicate with each other,” Tseng says. “In this case, we found that our transplanted HUMBLE cells secrete a molecule called nitric oxide, which is carried by red blood cells to the endogenous brown cells and activates those cells.”
If the HUMBLE technique continues to prove out in pre-clinical research, it might eventually be possible to generate this type of cell for individual patients, Tseng suggests. Such a procedure would remove a tiny amount of a patient’s white fat cells, isolate the progenitor cells, modify those cells to boost expression of UCP1, and then return the resulting HUMBLE cells to the patient.
However, that individualized approach would be complicated and expensive, so the Tseng lab is pursuing two alternative routes that may be more practical for clinical use.
One alternative is to use cells that are not personalized but instead are encapsulated via biomaterials that protect the cells from rejection by a patient’s immune system. (Joslin researchers and their collaborators have long studied such materials for cell transplants for type 1 diabetes.) The other option is gene therapies that directly express the UCP1 gene in white fat progenitor cells in the body, so that those cells acquire HUMBLE-like properties.
Tseng emphasizes that this research is moving ahead despite the Covid-19 pandemic, which puts people with diabetes at much higher risk of serious outcomes if they are infected.
“Employing cell-based or gene therapies to treat obesity or type 2 diabetes used to be science fiction,” she says. “Now scientific advances, such as CRISPR gene-editing technologies, will help us to improve the metabolism, the body weight, the quality of life and the overall health of people with obesity and diabetes.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Sliding backwards in obesity care: Workers see broad reductions and plateauing coverage in state employee health plans
New research published in Obesity has found that multiple state employee healthcare plans have reduced obesity treatment services for workers in the past five years. Conducted by the STOP Obesity ...
- Minimally Invasive Bariatric Procedure Effective for Milder Obesity
Minimally invasive endoscopic sleeve gastroplasty added to lifestyle modifications was effective for inducing significant weight loss, according to the randomized MERIT trial. Among patients with ...
- Study highlights the urgent need to evaluate deficiencies in the energy balance model for the prevention and treatment of obesity
In a new study, researchers highlighted the urgent need to substitute highly processed carbohydrates with minimally processed carbohydrates or healthy fats to cease the obesity pandemic that continues ...
- Ketogenic Diets in Binge-Eating Disorder With Obesity
Available treatments have limited effect on weight loss when binge-eating disorder is associated with obesity. Ketogenic diet has been proposed as a potential treatment for binge episodes in people ...
- Childhood obesity: Why are Indian children getting fatter?
India has long topped the list of countries with the highest number of stunted children in the world. It's now increasingly also reporting alarming levels of childhood obesity which, experts say, ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- BUDDY SCOTT: Love stems from the Father
It’s a two-way highway where water and nutrients consistently travel. It can grow a blueberry or a record 2,702 -pound pumpkin. I’m writing about the humble stem.
- Humble, organ-growing flatworms may hold key to slowing cancer in humans
Forsthoefel says regeneration research is a growing field and that flatworms and their similarities to humans are showing promising results. "What we discovered is a role for stored neutral lipids, or ...
- 400-year-old Ecuadoran beer resurrected from yeast
Inside an old oak barrel, Ecuadoran bioengineer Javier Carvajal found the fungus of fortune: a 400-year-old yeast specimen that he has since managed to resurrect and use to reproduce what is believed ...
- Review: Charlotte went wild for Kendrick Lamar. But did things have to end like that?
Yes, of course, when any big-name artist performs their big-name songs at a live show, fans are going to get pretty excited. This, though, felt different.
- Quick! Amazon's No. 1 bestselling zero-gravity lounger just dropped to $50 — save 45%
Made of UV-resistant textilene mesh, featuring an adjustable canopy and allowing easy snack and beverage access via a handy side tray, this lounger will turn your humble patio into the ultimate summer ...